Register
Login:
Share:
Email Facebook Twitter


Exclusive: Hardman & Co call the lithium market: is a change in trend happening?
Tower Resources identify 18 million barrels of contingent reserves worth $118M in Cameroon




Share Price Information for Immupharma (IMM)


Share Price: 12.30Bid: 11.80Ask: 12.30Change: 0.00 (0.00%)No Movement on Immupharma
Spread: 0.50Spread as %: 4.24%Open: 12.05High: 12.30Low: 12.00Yesterday’s Close: 12.30

Immupharma Plc Ord 10P

Immupharma is listed in the FTSE AIM All-Share
Immupharma is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
12.30
Share Price SpacerBid
11.80
Share Price SpacerAsk
12.30
Share Price SpacerChange
0%0.00
Share Price SpacerVolume
439,775
Share Price SpacerOpen
12.05
Share Price SpacerHigh
12.30
Share Price SpacerLow
12.00
Share Price SpacerClose
12.30
Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 139.47m £17.15m 15,000

52 Week High 193.00 52 Week High Date 4-JAN-2018
52 Week Low 9.06 52 Week Low Date 5-NOV-2018

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
19 60,983 243,792 -2.589 -4.75 0.00 0.00


London South East Users info for Immupharma




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

14-Dec-18
15:18:40
12.0556
135,000
Buy* 
11.80
12.30
16.28k
Trade Type:
Ordinary
Delayed publication

14-Dec-18
16:35:14
12.30
4
Buy* 
11.75
12.30
0.49
UT 
Trade Type:
Uncrossing Trade

14-Dec-18
16:22:16
12.30
2,867
Buy* 
11.80
12.30
352.64
Trade Type:
Automatic execution




View more Immupharma trades >>

Directors Deals for Immupharma (IMM)
Trade DateActionNotifierPriceCurrencyAmountHolding
30-Apr-15Notification of Holding
Trade Notifier Information for Immupharma
Stephane Robert George Mery held the position of Non-Executive Director at Immupharma at the time of this trade.
 Stephane Robert George Mery
002259
24-Jan-13Sell
Trade Notifier Information for Immupharma
Ajay Agrawal held the position of Non-Executive Director at Immupharma at the time of this trade.
 Ajay Agrawal
57GBX62,1690
24-Jan-12Buy
Trade Notifier Information for Immupharma
Ajay Agrawal held the position of Non-Executive Director at Immupharma at the time of this trade.
 Ajay Agrawal
80GBX62,1690
View more Immupharma directors dealings >>


Axebob
Posts: 1,678
Opinion:Strong Buy
Price:12.30
RE: sudden chunky buys into close
Fri 17:32
16k mabey the 4 is a call for more shares by mms
cthed
Posts: 418
Opinion:No Opinion
Price:12.30
RE: sudden chunky buys into close
Fri 16:50
What chunky buys. ..? Am I missing something? !
halfbutt
Posts: 109
Opinion:No Opinion
Price:12.30
RE: sudden chunky buys into close
Fri 16:38
I concur. ... somethings on the move.... similar to the big sell just before black Tuesday on the Monday . ..only this time in reverse ......... could be some leaky news ........
StockTracker
Posts: 536
Opinion:Strong Buy
Price:12.20
sudden chunky buys into close
Fri 15:38
is it a sign of news on Monday lets hope so
Nolupus
Posts: 858
Opinion:No Opinion
Price:12.05
RE: Things happening
Thu 17:28
StockTraker..Believe what you wish but imv the Nomad problem was not the real reason for the drop...It was the NO REASON behind the rise imo :-)
View more share chat for Immupharma (IMM) >>







Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.